These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 19668851)

  • 1. Metabolic profiling of Helicobacter pylori glycosylation.
    Koenigs MB; Richardson EA; Dube DH
    Mol Biosyst; 2009 Sep; 5(9):909-12. PubMed ID: 19668851
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeted identification of glycosylated proteins in the gastric pathogen Helicobacter pylori (Hp).
    Champasa K; Longwell SA; Eldridge AM; Stemmler EA; Dube DH
    Mol Cell Proteomics; 2013 Sep; 12(9):2568-86. PubMed ID: 23754784
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis of a natural oligosaccharide antibiotic active against Helicobacter pylori.
    Manabe S; Ishii K; Ito Y
    J Org Chem; 2007 Aug; 72(16):6107-15. PubMed ID: 17630800
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of glycoprotein receptors within the human salivary proteome for the lectin-like BabA and SabA adhesins of Helicobacter pylori by fluorescence-based 2-D bacterial overlay.
    Walz A; Odenbreit S; Stühler K; Wattenberg A; Meyer HE; Mahdavi J; Borén T; Ruhl S
    Proteomics; 2009 Mar; 9(6):1582-92. PubMed ID: 19253298
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel Helicobacter pylori therapeutic targets: the unusual suspects.
    Duckworth MJ; Okoli AS; Mendz GL
    Expert Rev Anti Infect Ther; 2009 Sep; 7(7):835-67. PubMed ID: 19735225
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protein glycosylation in Helicobacter pylori: beyond the flagellins?
    Hopf PS; Ford RS; Zebian N; Merkx-Jacques A; Vijayakumar S; Ratnayake D; Hayworth J; Creuzenet C
    PLoS One; 2011; 6(9):e25722. PubMed ID: 21984942
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A chemoenzymatic approach toward the rapid and sensitive detection of O-GlcNAc posttranslational modifications.
    Khidekel N; Arndt S; Lamarre-Vincent N; Lippert A; Poulin-Kerstien KG; Ramakrishnan B; Qasba PK; Hsieh-Wilson LC
    J Am Chem Soc; 2003 Dec; 125(52):16162-3. PubMed ID: 14692737
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glycosylated liposomes against Helicobacter pylori: behavior in acidic conditions.
    Bardonnet PL; Faivre V; Boullanger P; Ollivon M; Falson F
    Biochem Biophys Res Commun; 2009 May; 383(1):48-53. PubMed ID: 19324015
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anabolic utilization of steroid hormones in Helicobacter pylori.
    Hosoda K; Shimomura H; Hayashi S; Yokota K; Oguma K; Hirai Y
    FEMS Microbiol Lett; 2009 Aug; 297(2):173-9. PubMed ID: 19566683
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activities of urease and nickel uptake of Helicobacter pylori proteins are media- and host-dependent.
    Wolfram L; Bauerfeind P
    Helicobacter; 2009 Aug; 14(4):264-70. PubMed ID: 19674130
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A beta-1,4-galactosyltransferase from Helicobacter pylori is an efficient and versatile biocatalyst displaying a novel activity for thioglycoside synthesis.
    Namdjou DJ; Chen HM; Vinogradov E; Brochu D; Withers SG; Wakarchuk WW
    Chembiochem; 2008 Jul; 9(10):1632-40. PubMed ID: 18491328
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pathogenesis of Helicobacter pylori infection.
    Costa AC; Figueiredo C; Touati E
    Helicobacter; 2009 Sep; 14 Suppl 1():15-20. PubMed ID: 19712163
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of Rare Bacterial Monosaccharide Analogs for Metabolic Glycan Labeling in Pathogenic Bacteria.
    Clark EL; Emmadi M; Krupp KL; Podilapu AR; Helble JD; Kulkarni SS; Dube DH
    ACS Chem Biol; 2016 Dec; 11(12):3365-3373. PubMed ID: 27766829
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Surprise? Bacteria glycosylate proteins too.
    Tuomanen EI
    J Clin Invest; 1996 Dec; 98(12):2659-60. PubMed ID: 8981907
    [No Abstract]   [Full Text] [Related]  

  • 15. The effect of the human gut-signalling hormone, norepinephrine, on the growth of the gastric pathogen Helicobacter pylori.
    Doherty NC; Tobias A; Watson S; Atherton JC
    Helicobacter; 2009 Jun; 14(3):223-30. PubMed ID: 19702852
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 15-Deoxy-delta 12, 14,-prostaglandin J2 suppresses nuclear factor-kappaB-mediated apoptosis of Helicobacter pylori-infected gastric epithelial cells.
    Cha B; Kim KH; Kim H
    Ann N Y Acad Sci; 2009 Aug; 1171():457-63. PubMed ID: 19723089
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human gastrin: a true growth factor for Helicobacter pylori?
    Doherty N; Atherton JC
    Helicobacter; 2009 Aug; 14(4):303. PubMed ID: 19674135
    [No Abstract]   [Full Text] [Related]  

  • 18. Engineering sweet targets for magic bullets.
    Feizi T
    Nat Biotechnol; 2004 Oct; 22(10):1244-5. PubMed ID: 15470462
    [No Abstract]   [Full Text] [Related]  

  • 19. Evaluation of a new tumor necrosis factor-alpha-inducing membrane protein of Helicobacter pylori as a prophylactic vaccine antigen.
    Inoue K; Shiota S; Yamada K; Gotoh K; Suganuma M; Fujioka T; Ahmed K; Iha H; Nishizono A
    Helicobacter; 2009 Oct; 14(5):135-43. PubMed ID: 19751439
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of active efflux in antibiotic - resistance of clinical isolates of Helicobacter pylori.
    Falsafi T; Ehsani A; Niknam V
    Indian J Med Microbiol; 2009; 27(4):335-40. PubMed ID: 19736403
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.